Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12

Ana-Alicia Beltran-Bless, Mark Clemons, Christian Fesl, Richard Greil, Gregory R. Pond, Marija Balić, Lisa Vandermeer, Vesna Bjelic‐Radisic, Christian F. Singer, Guenther G. Steger, Ruth Helfgott, Daniel Egle, Lidija Sölkner, Simon Peter Gampenrieder, Stephanie Strobl, Christoph Suppan, Magdalena Ritter, Gabriel Rinnerthaler, Georg Pfeiler, Hannes Fohler, Dominik Hlauschek, John Hilton, Michael Gnant